Jhen-Ling Huang

Mrs. Jhen-Ling Huang

Chang Gung Memorial Hospital at Linkou
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJui-Yen Lin
Jui-Yen Lin
Eugene Yu-Chuan KangEugene Yu-Chuan Kang
Eugene Yu-Chuan Kang
ABAlay S. Banker
Alay S. Banker
KCKuan-Jen Chen
Kuan-Jen Chen
YHYih-Shiou Hwang
Yih-Shiou Hwang
Wei-Chi WuWei-Chi Wu
Wei-Chi Wu
This study aimed to compare the clinical performance between a smartphone-based fundus photography device and a contact imaging device for retinopathy of prematurity (ROP) screening. All patients were first examined with binocular indirect ophthalmoscopy (BIO), which served as the reference standard. The patients were then assessed by two devices. Imaging quality, ability to judge the zone and stage of ROP, agreement with the BIO results, vital signs, and pain scores were compared between these two devices. In total, 142 eyes of 71 infants were included. For the smartphone-based fundus photography, image quality was graded excellent or acceptable in 91.4% of examinations, although it was still significantly inferior to that of the contact imaging device (p < 0.001). The smartphone-based fundus photography images had moderate agreement with the BIO results regarding the presence or absence of plus disease (Cohen’s κ = 0.619), but evaluating the zone (p < 0.001) and stage (p < 0.001) of ROP was difficult. Systemic parameters, except for heart rate, were similar between the two imaging devices (all p > 0.05). In conclusion, although the smartphone-based fundus photography showed moderate agreement for determining the presence or absence of plus disease, it failed to identify the zone and stage of ROP.

WCWei Jen Cheng
Wei Jen Cheng
CCChihChao Chiang
ChihChao Chiang
MPMeng-Ting Peng
Meng-Ting Peng
YHYu-Tung HUANG
Yu-Tung HUANG
JHJhen-Ling Huang
Jhen-Ling Huang
THTsong-Long Hwang
Tsong-Long Hwang
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in Taiwan. Chronic obstructive pulmonary disease (COPD) is associated with CRC mortality in several population-based studies. However, this effect of COPD on CRC shows no difference in some studies and remains unclear in Taiwan’s population. Methods: We conducted a retrospective cohort study using Taiwan’s nationwide database. Patients newly diagnosed with CRC were identified from 2007 to 2012 via the Taiwan Cancer Registry dataset and linked to the National Health Insurance research database to obtain their medical records. Propensity score matching (PSM) was applied at a ratio of 1:2 in COPD and non-COPD patients with CRC. The 5-year overall survival (OS) was analyzed using the Cox regression method. Results: This study included 43,249 patients with CRC, reduced to 13,707 patients after PSM. OS was lower in the COPD group than in the non-COPD group. The adjusted hazard ratio (aHR) for COPD was 1.26 (95% confidence interval (CI), 1.19–1.33). Moreover, patients with CRC plus preexisting COPD showed a higher mortality risk in all stage CRC subgroup analysis. Conclusions: In this 5-year retrospective cohort study, patients with CRC and preexisting COPD had a higher mortality risk than those without preexisting COPD, suggesting these patients need more attention during treatment and follow-up.

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
TKTe-Chien Ku
Te-Chien Ku
PWPin-Han Wang
Pin-Han Wang
JHJhen-Ling Huang
Jhen-Ling Huang
HCHsing-Yu Chen
Hsing-Yu Chen
JFJi-Tseng Fang
Ji-Tseng Fang
JCJiun-Liang Chen
Jiun-Liang Chen

26 June 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
WYWen-Lin Yu
Wen-Lin Yu
YLYu-Ning Liao
Yu-Ning Liao
TYTsung-Hsien Yang
Tsung-Hsien Yang
CYChing-Wei Yang
Ching-Wei Yang
TKTing-I Kao
Ting-I Kao
HCHsing-Yu Chen
Hsing-Yu Chen
Background: Obesity is a global concern, driving the search for alternative treatments beyond lifestyle changes and medications. Laser acupuncture (LA) shows promise in obesity management, yet few studies compare it with FDA-approved medications. This study aimed to assess and compare LA’s impact with liraglutide on weight reduction in obese individuals. Methods: Data from the Chang Gung Research Database (CGRD) (2013–2018) were analyzed. Primary outcomes included changes in body weight and BMI within 180 days, with secondary outcomes measuring the proportion achieving 5%, 10%, and 15% weight loss. Adverse events were also assessed. Results: Of 745 subjects (173 LA users, 572 liraglutide users), LA users lost more weight by day 180 (5.82 ± 4.39 vs. 2.38 ± 5.75 kg; p < 0.001) and had a greater BMI reduction (−2.27 ± 1.73 vs. −0.93 ± 2.25 kg/m2; p < 0.001). More LA users achieved 5% and 10% weight loss compared to liraglutide users (64.2% vs. 22.7%, 26.6% vs. 4.2%; all p < 0.001). After balancing baseline differences, LA’s benefits remained significant. No adverse events were reported with LA. Conclusions: LA may offer superior weight reduction compared to liraglutide. Future studies should explore LA alone or in combination with liraglutide for obesity management.